Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$32M |
| 2 |
Plains GP Holdings
PAGP
|
+$26.5M |
| 3 |
FedEx
FDX
|
+$25.2M |
| 4 |
Boeing
BA
|
+$25.1M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$26.5M |
| 2 |
Tandem Diabetes Care
TNDM
|
+$21.1M |
| 3 |
CCC.U
Churchill Capital Corp
CCC.U
|
+$20.3M |
| 4 |
International Flavors & Fragrances
IFF
|
+$16.3M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.37% |
| 2 | Industrials | 14.55% |
| 3 | Consumer Discretionary | 13.2% |
| 4 | Technology | 10.71% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Norwegian Cruise Line
NCLH
$7.92B
| $2.02M | 0.08% |
47,666
-2,834
| -6% | -$137K |
|
|
LOXO
327
DELISTED
Loxo Oncology, Inc
LOXO
| $2M | 0.08% |
14,300
+4,300
| +43% | +$653K |
|
328
BJ's Restaurants
BJRI
$1.42B
| $2M | 0.08% |
+39,500
| New | +$2.38M |
|
329
Dillards
DDS
$9.71B
| $1.98M | 0.08% |
32,800
+16,300
| +99% | +$1.12M |
|
330
Hewlett Packard
HPE
$70.8B
| $1.95M | 0.07% |
147,537
+128,837
| +689% | +$1.93M |
|
331
Southwest Gas
SWX
$6.44B
| $1.95M | 0.07% |
+25,446
| New | +$2.04M |
|
332
Angi Inc
ANGI
$200M
| $1.95M | 0.07% |
+12,105
| New | +$2.19M |
|
333
Zai Lab
ZLAB
$2.92B
| $1.94M | 0.07% |
83,684
-85,916
| -51% | -$1.59M |
|
334
Truist Financial
TFC
$61.6B
| $1.94M | 0.07% |
+44,700
| New | +$2.15M |
|
335
Navient
NAVI
$886M
| $1.93M | 0.07% |
218,744
+132,844
| +155% | +$1.52M |
|
336
Ollie's Bargain Outlet
OLLI
$4.6B
| $1.92M | 0.07% |
28,901
-14,099
| -33% | -$1.17M |
|
337
Ashland
ASH
$3.33B
| $1.91M | 0.07% |
26,900
+17,400
| +183% | +$1.34M |
|
338
Baidu
BIDU
$31.6B
| $1.9M | 0.07% |
+12,000
| New | +$2.24M |
|
339
Lithia Motors
LAD
$8.15B
| $1.89M | 0.07% |
24,791
-4,909
| -17% | -$388K |
|
340
Alibaba
BABA
$286B
| $1.89M | 0.07% |
13,800
+9,000
| +188% | +$1.33M |
|
|
NAV
341
DELISTED
Navistar International
NAV
| $1.88M | 0.07% |
+72,460
| New | +$2.27M |
|
|
RTN
342
DELISTED
Raytheon Company
RTN
| $1.86M | 0.07% |
+12,138
| New | +$2.17M |
|
343
Teledyne Technologies
TDY
$29.5B
| $1.86M | 0.07% |
+8,965
| New | +$1.96M |
|
344
SLB Ltd
SLB
$79.9B
| $1.85M | 0.07% |
51,331
+17,831
| +53% | +$880K |
|
345
Church & Dwight Co
CHD
$23.4B
| $1.84M | 0.07% |
+28,000
| New | +$1.77M |
|
346
Crown Castle
CCI
$32.1B
| $1.84M | 0.07% |
16,943
-35,057
| -67% | -$3.85M |
|
347
Travere Therapeutics
TVTX
$6.19B
| $1.84M | 0.07% |
81,300
-19,700
| -20% | -$490K |
|
|
GRFS
348
Grifois
GRFS
$5.44B
| $1.84M | 0.07% |
100,100
-59,900
| -37% | -$1.19M |
|
349
Merit Medical Systems
MMSI
$5.42B
| $1.84M | 0.07% |
32,912
+112
| +0.3% | +$6.66K |
|
350
Murphy USA
MUSA
$10.5B
| $1.83M | 0.07% |
+23,900
| New | +$1.88M |
|
Similar funds
Steve Schonfeld's Q4 2018 Portfolio in Review
As of Q4 2018, Steve Schonfeld held 1,330 positions worth $2.6B, up 16% from $2.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Steve Schonfeld deployed $870M of net new capital in Q4 2018, opening 552 new positions and adding to 277 existing holdings. Its largest new stake was Shire pic: 183,006 shares worth $31.8M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Fortive, an estimated $26.5M trimmed.
- Steve Schonfeld's largest Q4 2018 buy was Shire pic: 183,006 shares worth $31.8M.
- Steve Schonfeld added most to Plains GP Holdings in Q4 2018, an estimated $26.5M increase.
- Steve Schonfeld's biggest Q4 2018 reduction was Fortive, cutting an estimated $26.5M.
- Steve Schonfeld fully exited Churchill Capital Corp in Q4 2018, selling an estimated $20.3M.
- Steve Schonfeld's ten largest holdings make up 13% of its $2.6B portfolio in Q4 2018.
- Steve Schonfeld opened 552 new positions and closed 296 in Q4 2018.
- Steve Schonfeld's portfolio value rose 16% quarter-over-quarter to $2.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.